Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antisense oligonucleotide therapeutics for human leukemia

A M Gewirtz1

  • 1Department of Pathology, University of Pennsylvania School of Medicine, Philadelphia 19104, USA.

Critical Reviews in Oncogenesis
|January 1, 1997
PubMed
Summary

Gene disruption technologies enable direct gene function investigation in cells. Antisense oligodeoxynucleotides offer therapeutic potential for diseases like cancer, despite ongoing research into their reliability and mechanism of action.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of Interleukin-1 α and Interleukin-1 β on Erythroid Progenitor Cell Growth in Serum Free Cultures: An In Vitro Study Relevant to the Pathogenesis of the Anemia of Chronic Disease.

Hematology (Amsterdam, Netherlands)·2016
Same author

Eltrombopag inhibition of acute myeloid leukemia cell survival does not depend on c-Mpl expression.

Leukemia·2012
Same author

Delivery and mechanistic considerations for the production of knock-in mice by single-stranded oligonucleotide gene targeting.

Gene therapy·2006
Same author

Progress in the development of nucleic acid therapeutics.

Handbook of experimental pharmacology·2006
Same author

2'-deoxy-2'-fluoro-beta-D-arabinonucleic acid (2'F-ANA) modified oligonucleotides (ON) effect highly efficient, and persistent, gene silencing.

Nucleic acids research·2006
Same author

Rationally targeted, conformationally constrained, oxetane-modified oligonucleotides demonstrate efficient gene-silencing activity in a cellular system.

Annals of the New York Academy of Sciences·2006

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Clinical Medicine

Background:

  • Gene disruption strategies are crucial for understanding gene function in specific cell types.
  • Understanding molecular pathogenesis of diseases, including cancer, is advancing rapidly.
  • Oligodeoxynucleotides are being explored for their potential to modify gene expression.

Purpose of the Study:

  • To review the successes and controversies surrounding oligodeoxynucleotides for gene expression modification.
  • To highlight the therapeutic potential of the antisense approach in clinical settings.
  • To discuss the challenges and future prospects of using gene modification techniques for treating diseases like CML.

Main Methods:

  • Review of existing literature on gene disruption strategies.

Related Experiment Videos

  • Analysis of oligodeoxynucleotide applications in cell and molecular biology.
  • Discussion of the mechanism of action, reliability, and therapeutic utility of antisense compounds.

    • Main Results:

    • Gene disruption tools allow direct investigation of gene function.
    • Oligodeoxynucleotides show promise in modifying gene expression.
    • Controversies exist regarding oligonucleotide mechanism, reliability, and therapeutic value.

    Conclusions:

    • The antisense approach holds significant therapeutic potential for various diseases.
    • Further research is needed to overcome challenges associated with oligonucleotide use.
    • Gene modification techniques are expected to contribute to managing CML and other neoplastic disorders.